Durect is headquartered in Cupertino, California.
Durect disclosed revenue of 2M USD for 2024 and 2M USD for 2023.
Durect is a life science company.
Durect was founded in 1988.
10240 Bubb Road,
Cupertino, California
95014
United States,
(408) 777-1417
www.durect.com
Durect is a late-stage biopharmaceutical company pioneering the development of epigenetic therapies that target dysregulated DNA methylation to transform the treatment of serious and life-threatening conditions, including acute organ injury. Durect was founded in 1988 and is based in Cupertino, California.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.0/yr) | # | - | - | - | - | - | - | 0 |
| Sell (0.2/yr) | # | - | - | - | - | 1 | - | 1 |
| vol | $18M | $18M | ||||||
| 1 | ||||||||
| Financial | Deals |
|---|---|
|
Aquilo Partners |
1 |
| Legal | Deals |
|---|---|
|
Wilson Sonsini Goodrich & Rosati |
1 |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
